Last reviewed · How we verify
NCT06734728
Post-marketing Study for the Evaluation of Profilm Cold Sores
NA trial testing Profilm Cold Sores in Cold Sores in 35 participants. Completed in 29 March 2023.
15 December 2022
Quick facts
| Lead sponsor | i+Med S.Coop. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 35 |
| Start date | 13 December 2022 |
| Primary completion | 15 December 2022 |
| Estimated completion | 29 March 2023 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Profilm Cold Sores
Conditions studied
- Cold Sores — all drugs for Cold Sores →
Sponsor
i+Med S.Coop. — full company profile →
Who can join
18 and older, any sex, with Cold Sores. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Experimental clinical study with a post-marketing, prospective, intra-subject controlled design to evaluate the efficacy and safety of the use of a medical device for the treatment of cold sores, over a maximum period of two weeks (or until the outbreak has resolved).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06734728
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other i+Med S.Coop. trials
Trials by the same sponsor.
- NCT07402395 — Clinical Study on the Safety and Efficacy of an Injectable Hyaluronic Acid for Improving the Aesthetic Rejuvenation of t · NA · completed
- NCT07533461 — Safety Test Under Gynecological Control to Evaluate Skin Acceptability of the Product in Female Volunteers · NA · completed
- NCT07533474 — Human In Use Test of GINPI-HP-004 in Healthy Adults · NA · completed
- NCT07301658 — Efficacy and Safety of Revodiol Calming Cream® in Atopic Dermatitis. · NA · completed
- NCT06732830 — Clinical Trial to Assess the Effectiveness of I+Med's DayDrop Advanced Ophthalmic Drop · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06734728 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by i+Med S.Coop.
- Last refreshed: 1 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06734728.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing